S
MREO

SignatureFD’s Mereo BioPharma MREO Stock Holding History

SignatureFD’s Portfolio MREO Stock Details MREO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-187
Closed -$507 – 3448
2025
Q2 		$507 Buy
+187
New +$451 ﹤0.01% 3107
2025
Q1 		– Sell
-679
Closed -$2.38K – 3401
2024
Q4 		$2.38K Hold
679
– – ﹤0.01% 2819
2024
Q3 		$2.79K Hold
679
– – ﹤0.01% 2736
2024
Q2 		$2.44K Sell
679
-141
-17% -$457 ﹤0.01% 2711
2024
Q1 		$2.71K Buy
+820
New +$2.78K ﹤0.01% 2717
2021
Q4 		– Sell
-138
Closed – – 3207
2021
Q3 		$0 Sell
138
-26
-16% -$69 ﹤0.01% 3153
2021
Q2 		$1K Buy
+164
New +$550 ﹤0.01% 2775

Other funds holding MREO

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SignatureFD's MREO Position: Q3 2025 in Review

SignatureFD sold out of Mereo BioPharma (MREO) in Q3 2025, closing a stake of 187 shares — an estimated $507 sold.

SignatureFD first reported a position in MREO in Q2 2021 and held it in 7 quarters. The position peaked at $2.79K in Q3 2024. 84 funds tracked by Wall St. Rank hold MREO as of Q3 2025.

  • SignatureFD reported no remaining Mereo BioPharma position as of Q3 2025 after selling out during the quarter.
  • SignatureFD sold 187 Mereo BioPharma shares in Q3 2025, an estimated $507.
  • SignatureFD first reported a position in Mereo BioPharma in Q2 2021 and held it in 7 quarters.
  • SignatureFD's Mereo BioPharma position peaked at $2.79K in Q3 2024.
  • 84 funds tracked by Wall St. Rank held Mereo BioPharma as of Q3 2025.

Based on SignatureFD's 13F filing for Q3 2025, filed 21 Oct 2025.